Jul 26, 2023 / 11:00AM GMT
Nick Stone -
Hello, everyone. Welcome to our half year and Q2 2023 conference call and webcast for investors and analysts. The presentation was sent to our distribution list by e-mail, and you can also find it on gsk.com.
Please turn to Slide 2. This is the usual safe harbor statement. We'll comment on our performance using constant exchange rates, or CER, unless stated otherwise. As a reminder, following the Consumer Healthcare demerger in 2022 to form Haleon, we're presenting performance and growth from the continuing operations for GSK.
Please turn to Slide 3. Today's call will last approximately 1 hour and management presentation will take between 30 to 35 minutes with the remaining time for your questions. (Operator Instructions) Our speakers today are Emma Walmsley, Tony Wood, Luke Miels, Deborah Waterhouse and Julie Brown, with David Redfern joining the rest of the team for the Q&A portion of the call.
Turning to Slide 4. I will now hand the call over to Emma.
Emma Natasha Walmsley - GSK plc - CEO & Director
Thanks, Nick, and
Q2 2023 GSK plc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot